Folgen
Alberto Clò
Alberto Clò
PhD presso Lab. Retrovirus, DIMES, Scuola di Medicina, Università di Bologna
Bestätigte E-Mail-Adresse bei unibo.it
Titel
Zitiert von
Zitiert von
Jahr
HIV-related mechanisms in atherosclerosis and cardiovascular diseases
D Gibellini, M Borderi, A Clò, S Morini, A Miserocchi, I Bon, C Ponti, ...
Journal of cardiovascular medicine 14 (11), 780-790, 2013
512013
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages
D Gibellini, A Clò, S Morini, A Miserocchi, C Ponti, MC Re
World Journal of Virology 2 (2), 91, 2013
502013
Prospective evaluation of bone markers, parathormone and 1, 25-(OH) 2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir …
E Focà, D Motta, M Borderi, D Gotti, L Albini, A Calabresi, I Izzo, ...
BMC infectious diseases 12 (1), 1-8, 2012
432012
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures
I Bon, D Lembo, M Rusnati, A Clo, S Morini, A Miserocchi, A Bugatti, ...
PLoS One 8 (10), e76482, 2013
412013
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells
D Gibellini, F Alviano, A Miserocchi, PL Tazzari, F Ricci, A Clò, S Morini, ...
Retrovirology 8 (1), 1-18, 2011
412011
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation
D Gibellini, E De Crignis, C Ponti, M Borderi, A Clò, A Miserocchi, P Viale, ...
Biochemical and biophysical research communications 401 (3), 429-434, 2010
372010
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line.
D Gibellini, M Borderi, E De Crignis, A Clo, A Miserocchi, P Viale, MC Re
The new microbiologica 33 (2), 109, 2010
372010
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified
MA Laginestra, PP Piccaluga, F Fuligni, M Rossi, C Agostinelli, S Righi, ...
Blood Cancer Journal 4 (11), e259-e259, 2014
322014
IFI16 expression is related to selected transcription factors during B-cell differentiation
PP Piccaluga, C Agostinelli, F Fuligni, S Righi, C Tripodo, MC Re, A Clò, ...
Journal of immunology research 2015, 2015
212015
Analysis of the effects of HIV‐1 Tat on the survival and differentiation of vessel wall‐derived mesenchymal stem cells
D Gibellini, A Miserocchi, PL Tazzari, F Ricci, A Clò, S Morini, C Ponti, ...
Journal of cellular biochemistry 113 (4), 1132-1141, 2012
212012
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients
A Clò, D Gibellini, D Damiano, F Vescini, C Ponti, S Morini, A Miserocchi, ...
New Microbiol 38 (3), 345-56, 2015
202015
Antiretroviral molecules and cardiovascular diseases
D Gibellini, M Borderi, A Clò, S Morini, A Miserocchi, I Bon, MC Re
New Microbiol 35 (4), 359-75, 2012
182012
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection
I Bon, A Clo, M Borderi, V Colangeli, L Calza, S Morini, A Miserocchi, ...
International Journal of Infectious Diseases 17 (10), e875-e882, 2013
122013
HIV‐1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy
I Bon, O Turriziani, G Musumeci, A Clò, C Montagna, S Morini, L Calza, ...
Journal of Medical Virology 87 (2), 315-322, 2015
82015
Recent and long-lasting infections: The need of avidity testing in HIV-1 infected subjects.
MC Re, I Bon, N Grandi, A Miserocchi, S Morini, A Clo, G Furlini, ...
Microbiologica-Quarterly Journal of Microbiological Sciences 35 (4), 407, 2012
82012
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol 2013; 2 (2): 91-101
D Gibellini, A Clò, S Morini, A Miserocchi, C Ponti, MC Re
4
Molecular bases of osteoporosis in HIV: the role of the virus and antiretroviral therapy
D Gibellini, M Borderi, E Vanino, A Clò, S Morini, L Calza, MC Re, P Viale
Clinical Reviews in Bone and Mineral Metabolism 10, 236-245, 2012
32012
Research Article IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation
PP Piccaluga, C Agostinelli, F Fuligni, S Righi, C Tripodo, MC Re, A Clò, ...
2015
Studio della patogenesi di HIV-1 nel compartimento osseo: effetti della terapia antiretrovirale convenzionale e nuovi approcci all'eradicazione
A Clò
alma, 2014
2014
BONE TURN-OVER MARKERS IN HIV POSITIVE PATIENTS AFTER HAART: TENOFOVIR (TDF) plus EMTRICITABINE (FTC) plus ATAZANAVIR/RITONAVIR (ATV/R)-VS.-TDF plus FTC plus EFAVIRENZ (EFV …
E Foca, D Motta, M Borderi, I Izzo, A Calabresi, R Bellagamba, R Fezza, ...
INFECTION 39, S42-S42, 2011
2011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20